We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Consulting Cardiologists Face an Imaging Paradigm Shift

By MedImaging International staff writers
Posted on 22 Mar 2017
Print article
In response to the rapid and unsustainable growth in the use of cardiac imaging procedures, the U.S. Centers for Medicare & Medicaid Service 2017 Medicare Physician Fee Schedule (MPFS) has confirmed the January 1, 2018, deadline for physicians to begin reporting on appropriate use criteria (AUC) interactions in order to receive payment for Medicare advanced imaging, as mandated by the Protecting Access to Medicare Act (PAMA) of 2014.

The AUC will serve as a guide for physicians to incorporate symptoms, risk factors, and clinical history in selecting the patients for whom testing is most appropriate, based on the best available evidence or expert consensus. AUC will also be part of a patient’s comprehensive disease management plan in order to maximize the value of care by minimizing unnecessary imaging and resultant downstream invasive procedures. It will thus help to avoid excess costs, enhances the value of imaging in risk stratification and decision-making, and reduce radiation risk, particularly in women.

The AUC will help physicians steer patients to alternative tests, or no testing at all, by classifying testing across a range of clinical scenarios in three categories: “appropriate” (established value); “may be appropriate” (uncertain value); and “rarely appropriate” (no clear value). From 2018, physicians will be required to use a clinical decision-support mechanisms (CDSM) for AUC consultation when ordering advanced imaging procedures, such as radionuclide imaging, magnetic resonance imaging (MRI), and computed tomography (CT); but other procedures, such as echocardiography, will be exempt.

“With the PAMA change, a massive shift will occur, wherein the burden of reducing inappropriate use moves largely from payers to providers. Most physicians are unprepared for this paradigm shift,” said Rami Doukky, MD, of John H. Stroger Jr. Hospital (Chicago, IL, USA), and colleagues, in an opinion piece published on February 28, 2017, in Annals of Internal Medicine. “Currently available CDSMs are often disjointed from the care process, and need to be integrated more seamlessly into EHR systems to provide real-time guidance with the least provider burden.”

Professional organizations such as the American College of Cardiology and the American College of Radiology have established multidisciplinary autonomous teams for rigorous, systematic review of published literature and consensus guidelines in order to construct detailed AUCs, with transparency of the methodology supporting appropriate use determination, and full disclosure of potential conflicts of interest. Radiology benefits management programs and insurance companies are specifically excluded from this process.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound Software
UltraExtend NX
New
Brachytherapy Planning System
Oncentra Brachy
Laptop Ultrasound Scanner
PL-3018

Print article
Radcal

Channels

MRI

view channel
Image: Exablate Prime features an enhanced user interface and enhancements to optimize productivity (Photo courtesy of Insightec)

Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery

Essential tremor, often called familial, idiopathic, or benign tremor, leads to uncontrollable shaking that significantly affects a person’s life. When traditional medications do not alleviate symptoms,... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.